Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$71.21
+1.3%		$74.72
$42.10
▼
$92.56
$23.71B3.615.71 million shs3.92 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$154.03
-2.6%		$99.71
$22.28
▼
$176.66
$63.11B1.120.99 million shs20.23 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affirm Holdings, Inc. stock logo
AFRM
Affirm
+1.32%-0.32%-7.91%-3.67%-21.23%
Moderna, Inc. stock logo
MRNA
Moderna
-2.56%+6.99%-11.67%+140.82%+516.12%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$71.21
+1.3%		$74.72
$42.10
▼
$92.56
$23.71B3.615.71 million shs3.92 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$154.03
-2.6%		$99.71
$22.28
▼
$176.66
$63.11B1.120.99 million shs20.23 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Affirm Holdings, Inc. stock logo
AFRM
Affirm
+1.32%-0.32%-7.91%-3.67%-21.23%
Moderna, Inc. stock logo
MRNA
Moderna
-2.56%+6.99%-11.67%+140.82%+516.12%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2.75
Moderate Buy$98.7838.71% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.08
Hold$76.72-50.19% Downside

Current Analyst Ratings Breakdown

Latest MRNA and AFRM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/16/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$85.00
9/16/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform$85.00
9/9/2026
Moderna, Inc. stock logo
MRNA
Moderna
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/9/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
9/9/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$105.00
9/8/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$105.00
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$81.00
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Sell
9/3/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$83.00 ➝ $85.00
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral ➝ Sell$40.00 ➝ $81.00
9/2/2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
Scotiabank logo
Scotiabank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSector Outperform$95.00
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$4.26B5.64$5.83 per share12.22$16.26 per share4.38
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B31.63N/AN/A$22.14 per share6.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$1.93B$5.5212.9024.812.8745.29%47.91%14.46%11/5/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$7.99N/AN/AN/A-141.43%-28.30%-19.39%11/5/2026 (Estimated)

Latest MRNA and AFRM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/27/2026Q4 2026
Affirm Holdings, Inc. stock logo
AFRM
Affirm
$0.3473$4.62+$4.2727$4.62$1.11 billion$1.07 billion
7/31/2026Q2 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$2.03-$1.97+$0.06-$1.97$102.93 million$145.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Affirm Holdings, Inc. stock logo
AFRM
Affirm
N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Affirm Holdings, Inc. stock logo
AFRM
Affirm
1.82
11.80
11.80
Moderna, Inc. stock logo
MRNA
Moderna
0.09
2.29
2.18

Institutional Ownership

CompanyInstitutional Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
69.29%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
Affirm Holdings, Inc. stock logo
AFRM
Affirm
11.01%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Affirm Holdings, Inc. stock logo
AFRM
Affirm
2,358337.42 million300.27 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700399.24 million356.12 millionOptionable

Recent News About These Companies

Moderna (MRNA) Dropped, So What Is Behind The Latest Attention?
September 19 at 7:19 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/moderna-mrna-dropped-behind-latest-071602863.html
Insider Selling: Moderna (NASDAQ:MRNA) President Sells $5,807,574.22 in Stock
September 19 at 5:11 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31033487
Moderna (NASDAQ:MRNA) President Sells $5,883,845.67 in Stock
September 19 at 5:11 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31033478
Bank of America Corp DE Invests $98.72 Million in Moderna, Inc. $MRNA
September 19 at 3:06 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-invests-9872-million-in-moderna-inc-mrna-2026-09-19/
Moderna (NASDAQ:MRNA) Shares Down 2.6% - What's Next?
September 18 at 5:20 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-moderna-nasdaq-mrna-shares-down-26-whats-next-2026-09-18/
Biotech Stocks To Research - September 15th
September 18 at 3:03 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31030117
Moderna continues volatile trading with 9% gain
September 17 at 6:34 PM  |  seekingalpha.comhttps://seekingalpha.com/news/4644107-moderna-continues-volatile-trading-with-9-gain
Why Are Moderna (MRNA) Shares Soaring Today
September 17 at 6:34 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/why-moderna-mrna-shares-soaring-204217170.html
Moderna (NASDAQ:MRNA) Trading 8.5% Higher - Time to Buy?
September 17 at 5:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-moderna-nasdaq-mrna-trading-85-higher-time-to-buy-2026-09-17/
Moderna stock rises 8%: can it continue its cancer vaccine success rally?
September 17 at 2:23 PM  |  invezz.comI
Moderna Stock Is Surging: What's Going On?
September 17 at 1:02 PM  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/09/61851165/moderna-stock-is-surging-whats-going-on?utm_source=snapi
Biotech Stocks To Keep An Eye On - September 17th
September 17 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-biotech-stocks-to-keep-an-eye-on-september-17th-2026-09-17/
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
September 17 at 9:50 AM  |  247wallst.comhttps://247wallst.com/investing/2026/09/17/moderna-climbs-6-as-cancer-vaccine-trade-extends-a-137-month-biontech-and-novavax-edge-higher/?utm_source=snapi
This tiny biotech is beating MRNA, IOVA and SLS — here's how a billionaire fueled its September rally
September 17 at 8:33 AM  |  msn.comhttps://www.msn.com/en-us/news/other/this-tiny-biotech-is-beating-mrna-iova-and-sls-heres-how-a-billionaire-fueled-its-september-rally/ar-AA2cpDtO
Insider Selling: Moderna (NASDAQ:MRNA) President Sells 40,294 Shares of Stock
September 17 at 6:22 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mrna-insider-buying-and-selling-2026-09-17/
Moderna (NASDAQ:MRNA) Stock Price Down 2% on Insider Selling
September 17 at 1:52 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027876
Moderna (NASDAQ:MRNA) Shares Up 1.3% - Should You Buy?
September 16 at 5:20 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-moderna-nasdaq-mrna-shares-up-13-should-you-buy-2026-09-16/
Stephen Hoge Sells 40,294 Shares of Moderna (NASDAQ:MRNA) Stock
September 16 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-stephen-hoge-sells-40294-shares-of-moderna-nasdaq-mrna-stock-2026-09-16/
Insider Selling: Moderna (NASDAQ:MRNA) President Sells $5,883,845.67 in Stock
September 16 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-moderna-nasdaq-mrna-president-sells-588384567-in-stock-2026-09-16/
Breakfast News: Why Merck Should Buy Moderna
September 16 at 12:29 PM  |  fool.comhttps://www.fool.com/investing/breakfast-news/2026/09/16/breakfast-news-why-merck-should-buy-moderna/
Promising Biotech Stocks To Consider - September 16th
September 16 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-biotech-stocks-to-consider-september-16th-2026-09-16/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
Moderna logo displayed in a laboratory setting with a vaccine vial, petri dishes, and a microscope.
Moderna’s 177% Surge Has Investors Asking What Comes Next
By Sam Quirke | August 21, 2026
Scientist handles blood sample in lab, symbolizing early cancer detection.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
By Bridget Bennett | September 6, 2026
Affirm stock logo

Affirm NASDAQ:AFRM

$71.21 +0.93 (+1.32%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$71.18 -0.03 (-0.05%)
As of 09/18/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months. The company has active merchants covering small businesses, large enterprises, direct-to-consumer brands, brick-and-mortar stores, and companies with an omni-channel presence. Its merchants represent a range of industries, including sporting goods and outdoors, furniture and homewares, travel and ticketing, apparel, accessories, consumer electronics, and jewelry. Affirm Holdings, Inc. was founded in 2012 and is headquartered in San Francisco, California.

Moderna stock logo

Moderna NASDAQ:MRNA

$154.03 -4.04 (-2.56%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$153.90 -0.13 (-0.09%)
As of 09/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas